Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”

被引：0
|
作者：
Eric J. Lenze
Angela M. Reiersen
Shelley N. Facente
机构：
[1] Washington University in St. Louis,
[2] University of California,undefined
[3] Berkeley,undefined
来源：
Drugs | 2022年 / 82卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 354
页数：1
相关论文
共 50 条
  • [1] Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence"
    Lenze, Eric J.
    Reiersen, Angela M.
    Facente, Shelley N.
    DRUGS, 2022, 82 (03) : 353 - 354
  • [2] Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
    Shelley N. Facente
    Angela M. Reiersen
    Eric J. Lenze
    David R. Boulware
    Jeffrey D. Klausner
    Drugs, 2021, 81 : 2081 - 2089
  • [3] Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
    Facente, Shelley N.
    Reiersen, Angela M.
    Lenze, Eric J.
    Boulware, David R.
    Klausner, Jeffrey D.
    DRUGS, 2021, 81 (18) : 2081 - 2089
  • [4] Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence"
    Mazza, Mario Gennaro
    Vai, Benedetta
    De Picker, Livia
    Benedetti, Francesco
    Zanardi, Raffaella
    DRUGS, 2022, 82 (03) : 349 - 351
  • [5] Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
    Mario Gennaro Mazza
    Benedetta Vai
    Livia De Picker
    Francesco Benedetti
    Raffaella Zanardi
    Drugs, 2022, 82 : 349 - 351
  • [6] Reply to Fillmore et al.: Additional evidence of non-SARS-CoV-2 coronavirus cross-immunity
    Solomon, Matthew D.
    Steinman, Lawrence
    Liu, Vincent X.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (46)
  • [7] Integrating New Evidence About an Old Drug: Authors' Reply to Franco et al. and Bell et al.
    Spruyt, Odette
    Le, Brian H.
    Philip, Jennifer
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (04) : E4 - E5
  • [8] Current evidence of SARS-CoV-2 infection in pregnancy: A scoping review
    Romero, Angel Flaminio Guiza
    Agudelo, Gabriela Saldana
    Gualdron, Lucy Marcela Vesga
    REVISTA CUIDARTE, 2022, 13 (01)
  • [9] Authors' reply to Thomas et al.'s "Comment on 'Early treatment with activated protein C for meningococcal septic shock: case report and literature review' by Hasin et al."
    Hasin, T
    Lebowitz, D
    Rot, D
    Wiess, Y
    Chajek-Shaul, T
    Nir-Paz, R
    INTENSIVE CARE MEDICINE, 2005, 31 (12) : 1730 - 1730
  • [10] Authors’ reply to Thomas et al.’s “Comment on ‘Early treatment with activated protein C for meningococcal septic shock: case report and literature review’ by Hasin et al.”
    Tal Hasin
    David Lebowitz
    David Rot
    Yoram Wiess
    Tova Chajek-Shaul
    Ran Nir-Paz
    Intensive Care Medicine, 2005, 31 : 1730 - 1730
12345